BREAKING
Home » Archive by Category "Vaccines" (Page 3)

Costa Rica: Immunosuppressed population will receive third COVID-19 dose in 2022

By

By NewsDesk  @infectiousdiseasenews In Costa Rica, the National Vaccination and Epidemiology Commission (CNVE) indicated that immunosuppressed people are included within the population to be vaccinated...

Chile: COVID-19 cases down, No commune in the country is in quarantine

By

By NewsDesk  @infectiousdiseasenews The Minister of Health, Enrique Paris, reported that “763 new cases are reported, with a positivity of 1.23% in the last 24 hours nationwide with 61,188 exams,...

Sweden: 40% of people born in 2003-2005 had received their first dose of COVID-19 vaccine

By

By NewsDesk  @infectiousdiseasenews On Thursday, the Swedish Public Health Agency reports new figures for vaccination coverage in the youngest target group. At least 39.8 percent of young people born...

Philippines report 14K COVID-19 cases Saturday, FDA describes success of vaccine

By

By NewsDesk  @infectiousdiseasenews The Philippines Department of Health (DOH) reported 14,249 additional COVID-19 cases on Saturday, exemplifying the current rise in cases in the country. In addition,...

FDA gives OK for booster COVID-19 vaccine dose in certain immunocompromised people, AMA statement

By

By NewsDesk  @infectiousdiseasenews On Thursday, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19...

CDC: Vaccine safe for pregnant women

By

NewsDesk @bactiman63 CDC has released new data on the safety of the COVID-19 vaccines in pregnant women and is recommending all people 12 years of age and older get vaccinated against COVID-19. “CDC...

Finland reports 60% of 16-19 year old’s have received 1st COVID jab

By

NewsDesk @bactiman63 Almost 67 percent of the Finnish population has received the first dose of coronary vaccine. There are now just under 3.7 million taking the first dose, health officials report. “The...

Portugal’s analysis of vaccinating adolescents aged 12-15 years against COVID-19

By

The issues related to vaccination against COVID-19 in children and adolescents are complex and, within the framework of technical recommendations, the available scientific data were analyzed for a well-founded...

Chikungunya vaccine candidate Phase 3 trial: Induced neutralizing antibody titers in 98.5% of subjects after a single vaccination

By

Specialty vaccine company, Valneva, announced positive topline results from the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553. VLA1553 was recently awarded Breakthrough...

Middle East respiratory syndrome coronavirus

MERS vaccine candidate enters Phase 2 trial

By

NewsDesk @bactiman63 Pennsylvania-based Inovio announced today that the company has dosed the first Phase 2 trial subject in its quest to develop the first vaccine against the Middle East Respiratory...